DeepHealth, Inc., a world chief in AI-powered well being informatics and a wholly-owned subsidiary of RadNet, Inc., will introduce next-generation AI-powered radiology informatics and inhabitants screening options on the European Congress of Radiology (ECR) 2025 in Vienna. With the purpose of empowering breakthroughs in care enabled by imaging, DeepHealth’s suite of options addresses vital scientific and operational challenges skilled by healthcare suppliers around the globe. DeepHealth’s options are powered by DeepHealth OS, a safe, scalable, and cloud-native working system that integrates knowledge throughout numerous options and permits interoperability with broader healthcare IT ecosystems. Furthermore, to allow AI adoption at scale, DeepHealth has established strategic collaborations enabling built-in options with ecosystem trade leaders.
“At DeepHealth, we’re harnessing the transformative energy of AI to create cutting-edge options which might be deeply rooted in real-world scientific wants,” stated Kees Wesdorp, PhD, President and CEO of RadNet’s Digital Well being division.
We imagine that AI adoption at scale in radiology can solely be achieved by embedding AI into and unifying knowledge throughout scientific and operational workflows to empower radiologists and care groups that in the present day are having to depend on disconnected units and disparate knowledge sources. At ECR 2025, we’re excited to showcase our next-generation radiology informatics and inhabitants screening options designed to reinforce operational effectivity, scientific confidence, and care supply throughout the radiology continuum.”
Kees Wesdorp, PhD, President and CEO, RadNet’s Digital Well being division
Streamlining workflows with next-generation radiology informatics options
DeepHealth goals to convey to European prospects its newest improvements that harness the ability of AI to streamline operations, help larger volumes of sufferers, and help radiologists and care groups in diagnosing sufferers quicker and with higher accuracy.
At ECR 2025, DeepHealth will showcase Diagnostic Suite™, which harnesses the cloud-native capabilities of DeepHealth OS to set a brand new benchmark in medical imaging expertise and the normal Image Archiving and Communication System (PACS). Diagnostic Suite delivers a unified AI-powered interpretive expertise that’s supposed to seamlessly combine with or exchange present RIS/PACS methods, bringing superior capabilities to fulfill the evolving calls for of radiologists. A unified software, the diagnostic workspace brings collectively worklist, affected person temporary, reporting, and high-speed streaming viewer applied sciences with superior visualization and AI orchestration capabilities. Diagnostic Suite is cloud-native, enabling excessive reliability and scalability to practices of all sizes and scale.
DeepHealth can be asserting upcoming updates to SmartMammo™, a complete suite of superior instruments designed to optimize breast most cancers screening and prognosis for extra environment friendly workflows, which is able to help 2D mammograms, additional enhancing native workflow integration. DeepHealth’s 3D answer is suitable with main OEMs and integrates seamlessly with radiologist worklists and reporting instruments. It options scientific AI detection capabilities that mechanically localize lesions and assess suspicion ranges throughout various populations and dense breast tissue, enabling a 21% enhance in most cancers detection price. The updates will incorporate already CE-marked 2D expertise to help within the major learn and fulfill the second reader position in mammography double studying workflows.
State-of-the-art scientific AI options for lung, prostate, and mind well being
DeepHealth may also showcase its newest scientific outcomes and have updates to its broader inhabitants well being portfolio. DeepHealth’s scientific AI options embody complete, end-to-end AI-powered options for scientific diagnostics and high-volume screening in lung, breast, and prostate well being, together with AI-driven improvements for mind well being. DeepHealth’s options are powering screening applications for breast most cancers within the US and lung most cancers in Europe.
DeepHealth’s AI-powered Lung answer is used to help radiologists within the NHS England’s Lung Most cancers Screening Program, one of many world’s largest lung most cancers screening initiatives. Inside this program, 76% of detected cancers had been caught at earlier, extra treatable phases, in comparison with solely 29% traditionally (with out AI). The answer supplies AI-powered nodule detection, reporting, and affected person administration for enhanced effectivity and accuracy in lung most cancers prognosis by mechanically detecting and segmenting lung nodules, enabling radiologists to interpret lung CT scans extra confidently and, in line with a latest research, as much as 42% quicker.
In prostate most cancers, DeepHealth’s AI-powered Prostate answer helps high-volume inhabitants well being screening applications, diagnostic interpretation, and biopsy planning enabled by automated prostate segmentation, standardized reporting, and integration with most fusion biopsy methods. The answer has been proven to allow a 97% diagnostic sensitivity, up from 92% for radiologists with out AI help and up to date analyses revealed a 37% discount in workflow time for MRI learn.
Components of DeepHealth’s portfolio are already delivering significant influence for sufferers and healthcare suppliers around the globe, with over 800 scientific websites and greater than 3,000 radiologists leveraging its present RIS, PACS, and AI options to ship higher care.
At ECR 2025, DeepHealth’s portfolio of options is offered at Sales space no. 507, X5.
